Replies to post #196204 on Biotech Values

[DewDiligence]

RLYP -29%/PM—either the FDA label for Veltassa is worse than expected or this morning’s CC did not go well (or both).

[whatisthecolorofmone]

Thanks. Backfired

Not in the money....lol. Unless confirm QE in the place, market will behave like this.